In silico prediction of telomerase reverse transcriptase inhibitors using modified retinol for the treatment of arsenical cancer

Authors

  • Kipchu Tshering Division of Arsenic Research, Department of Pharmacology, Bangabandhu Sheikh Mujib Medical University, Kazi Nazrul Islam Avenue, Shahbag, Dhaka
  • Mir Misbahuddin Division of Arsenic Research, Department of Pharmacology, Bangabandhu Sheikh Mujib Medical University, Kazi Nazrul Islam Avenue, Shahbag, Dhaka http://orcid.org/0000-0003-4667-1005

DOI:

https://doi.org/10.3329/bsmmuj.v9i3.29650

Keywords:

Arsenic, Cancer, In silico, Molecular docking, Retinol, Telomerase reverse transcriptase

Abstract

Retinol molecule was modified to predict the inhibitors of telomerase reverse transcriptase for the treatment of arsenical cancer through in silico study. Telomerase activity is expressed in the cancerous conditions which can be the target for anticancer activity by inhibiting telomerase reverse transcriptase enzyme. The inhibitors were predicted through molecular docking of modified retinol with telomerase reverse transcriptase. Taking into account of low binding energy and high binding affinity two new compounds, compound number 606 and compound number 609 were predicted as the inhibitors of telomerase reverse transcriptase for the treatment of arsenical cancer. The prediction of these two compounds was further supported by drug-likeness test through Administration, Distribution, Metabolism, Excretion and Toxicity evaluation. The compounds were also compared with some of the known inhibitors of telomerase reverse transcriptase. 

Downloads

Download data is not yet available.
Abstract
867
Download
773 Read
574

Author Biography

Mir Misbahuddin, Division of Arsenic Research, Department of Pharmacology, Bangabandhu Sheikh Mujib Medical University, Kazi Nazrul Islam Avenue, Shahbag, Dhaka

Professor

Cell: 880-1849396067; email: dgdabd@gmail.com

ORCHID ID: 0000-0003-4667-1005

Google Scholar Citation Index

 

Published

2016-09-21

How to Cite

Tshering, K., & Misbahuddin, M. (2016). In silico prediction of telomerase reverse transcriptase inhibitors using modified retinol for the treatment of arsenical cancer. Bangabandhu Sheikh Mujib Medical University Journal, 9(3), 164–168. https://doi.org/10.3329/bsmmuj.v9i3.29650

Issue

Section

Original Articles